-transparent.png){kind=logo}
It was shown that 3-amino-3-deoxy-D-glucose, one of the constituents of the kanamycin molecule and a metabolite of Bacillus sp., inhibits the bacterial synthesis of cell wall. The antibiotic (100 microgram/ml) significantly inhibits the growth of Staphylococcus aureus FDA 209P as well as the incorporation of DL-[14C]alanine into the acid-insoluble macromolecular fraction of its growing cells in the presence of chloramphenicol (100 microgram/ml). In contrast, the antibiotic does not affect the incorporation of [3H]thymidine, [3H]uridine and L-[14C]leucine. The other constituents of kanamycin, 6-amino-6-deoxy-D-glucose and deoxystreptamine do not inhibit the synthesis of bacterial cell wall peptidoglycan.
Y Iwai, and
H Tanaka, and
R Oiwa, and
S Shimizu, and
S Omura
August 1968,
The Journal of antibiotics,
Y Iwai, and
H Tanaka, and
R Oiwa, and
S Shimizu, and
S Omura
November 1966,
Angewandte Chemie (International ed. in English),
Y Iwai, and
H Tanaka, and
R Oiwa, and
S Shimizu, and
S Omura
November 1967,
The Journal of antibiotics,
Y Iwai, and
H Tanaka, and
R Oiwa, and
S Shimizu, and
S Omura
July 1962,
Chemical & pharmaceutical bulletin,
Y Iwai, and
H Tanaka, and
R Oiwa, and
S Shimizu, and
S Omura
September 1973,
Journal of bacteriology,
Y Iwai, and
H Tanaka, and
R Oiwa, and
S Shimizu, and
S Omura
October 1972,
The Journal of organic chemistry,
Y Iwai, and
H Tanaka, and
R Oiwa, and
S Shimizu, and
S Omura
February 1965,
The Journal of organic chemistry,
Y Iwai, and
H Tanaka, and
R Oiwa, and
S Shimizu, and
S Omura
October 1967,
Bulletin of the Chemical Society of Japan,
Y Iwai, and
H Tanaka, and
R Oiwa, and
S Shimizu, and
S Omura
April 1987,
Experientia,
Y Iwai, and
H Tanaka, and
R Oiwa, and
S Shimizu, and
S Omura
October 1995,
Carbohydrate research,
